| UniProt ID | AEBP1_HUMAN | |
|---|---|---|
| UniProt AC | Q8IUX7 | |
| Protein Name | Adipocyte enhancer-binding protein 1 | |
| Gene Name | AEBP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1158 | |
| Subcellular Localization |
Isoform 1: Secreted . Isoform 2: Cytoplasm . Nucleus . |
|
| Protein Description | May positively regulate MAP-kinase activity in adipocytes, leading to enhanced adipocyte proliferation and reduced adipocyte differentiation. May also positively regulate NF-kappa-B activity in macrophages by promoting the phosphorylation and subsequent degradation of I-kappa-B-alpha (NFKBIA), leading to enhanced macrophage inflammatory responsiveness. Can act as a transcriptional repressor.. | |
| Protein Sequence | MAAVRGAPLLSCLLALLALCPGGRPQTVLTDDEIEEFLEGFLSELEPEPREDDVEAPPPPEPTPRVRKAQAGGKPGKRPGTAAEVPPEKTKDKGKKGKKDKGPKVPKESLEGSPRPPKKGKEKPPKATKKPKEKPPKATKKPKEKPPKATKKPKEKPPKATKKPPSGKRPPILAPSETLEWPLPPPPSPGPEELPQEGGAPLSNNWQNPGEETHVEAREHQPEPEEETEQPTLDYNDQIEREDYEDFEYIRRQKQPRPPPSRRRRPERVWPEPPEEKAPAPAPEERIEPPVKPLLPPLPPDYGDGYVIPNYDDMDYYFGPPPPQKPDAERQTDEEKEELKKPKKEDSSPKEETDKWAVEKGKDHKEPRKGEELEEEWTPTEKVKCPPIGMESHRIEDNQIRASSMLRHGLGAQRGRLNMQTGATEDDYYDGAWCAEDDARTQWIEVDTRRTTRFTGVITQGRDSSIHDDFVTTFFVGFSNDSQTWVMYTNGYEEMTFHGNVDKDTPVLSELPEPVVARFIRIYPLTWNGSLCMRLEVLGCSVAPVYSYYAQNEVVATDDLDFRHHSYKDMRQLMKVVNEECPTITRTYSLGKSSRGLKIYAMEISDNPGEHELGEPEFRYTAGIHGNEVLGRELLLLLMQYLCREYRDGNPRVRSLVQDTRIHLVPSLNPDGYEVAAQMGSEFGNWALGLWTEEGFDIFEDFPDLNSVLWGAEERKWVPYRVPNNNLPIPERYLSPDATVSTEVRAIIAWMEKNPFVLGANLNGGERLVSYPYDMARTPTQEQLLAAAMAAARGEDEDEVSEAQETPDHAIFRWLAISFASAHLTLTEPYRGGCQAQDYTGGMGIVNGAKWNPRTGTINDFSYLHTNCLELSFYLGCDKFPHESELPREWENNKEALLTFMEQVHRGIKGVVTDEQGIPIANATISVSGINHGVKTASGGDYWRILNPGEYRVTAHAEGYTPSAKTCNVDYDIGATQCNFILARSNWKRIREIMAMNGNRPIPHIDPSRPMTPQQRRLQQRRLQHRLRLRAQMRLRRLNATTTLGPHTVPPTLPPAPATTLSTTIEPWGLIPPTTAGWEESETETYTEVVTEFGTEVEPEFGTKVEPEFETQLEPEFETQLEPEFEEEEEEEKEEEIATGQAFPFTTVETYTVNFGDF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 95 | Acetylation | EKTKDKGKKGKKDKG HHCCCCCCCCCCCCC | 65.18 | 7265039 | |
| 96 | Acetylation | KTKDKGKKGKKDKGP HCCCCCCCCCCCCCC | 82.00 | 7265049 | |
| 109 | Phosphorylation | GPKVPKESLEGSPRP CCCCCHHHCCCCCCC | 37.54 | 23312004 | |
| 113 | Phosphorylation | PKESLEGSPRPPKKG CHHHCCCCCCCCCCC | 14.36 | 69467865 | |
| 134 | Acetylation | ATKKPKEKPPKATKK CCCCCCCCCCCCCCC | 73.14 | 7978621 | |
| 137 | Acetylation | KPKEKPPKATKKPKE CCCCCCCCCCCCCCC | 76.77 | 7978631 | |
| 145 | Acetylation | ATKKPKEKPPKATKK CCCCCCCCCCCCCCC | 73.14 | 7978641 | |
| 148 | Acetylation | KPKEKPPKATKKPKE CCCCCCCCCCCCCCC | 76.77 | 7978651 | |
| 156 | Acetylation | ATKKPKEKPPKATKK CCCCCCCCCCCCCCC | 73.14 | 7978661 | |
| 159 | Acetylation | KPKEKPPKATKKPPS CCCCCCCCCCCCCCC | 76.77 | 7978671 | |
| 176 | O-linked_Glycosylation | RPPILAPSETLEWPL CCCCCCCCCCCCCCC | 37.29 | OGP | |
| 188 | O-linked_Glycosylation | WPLPPPPSPGPEELP CCCCCCCCCCCCCCC | 48.54 | OGP | |
| 203 | O-linked_Glycosylation | QEGGAPLSNNWQNPG CCCCCCCCCCCCCCC | 27.36 | OGP | |
| 228 | O-linked_Glycosylation | QPEPEEETEQPTLDY CCCCCCCCCCCCCCC | 43.11 | OGP | |
| 228 | Phosphorylation | QPEPEEETEQPTLDY CCCCCCCCCCCCCCC | 43.11 | 113325363 | |
| 232 | Phosphorylation | EEETEQPTLDYNDQI CCCCCCCCCCCCCCC | 31.77 | 113325369 | |
| 232 | O-linked_Glycosylation | EEETEQPTLDYNDQI CCCCCCCCCCCCCCC | 31.77 | OGP | |
| 347 | Phosphorylation | KKPKKEDSSPKEETD HCCCCCCCCCCHHHH | 50.02 | 26657352 | |
| 404 | Phosphorylation | DNQIRASSMLRHGLG CCCHHHHHHHHHCCC | 22.35 | 19664995 | |
| 429 | Phosphorylation | GATEDDYYDGAWCAE CCCCCCCCCCCEECC | 18.20 | 23872183 | |
| 523 | Phosphorylation | VARFIRIYPLTWNGS HHHEEEEEEECCCCC | 5.15 | 24260401 | |
| 526 | Phosphorylation | FIRIYPLTWNGSLCM EEEEEEECCCCCCCC | 16.63 | 24260401 | |
| 528 | N-linked_Glycosylation | RIYPLTWNGSLCMRL EEEEECCCCCCCCEE | 25.58 | 19159218 | |
| 530 | Phosphorylation | YPLTWNGSLCMRLEV EEECCCCCCCCEEEE | 18.38 | 24260401 | |
| 575 | Ubiquitination | KDMRQLMKVVNEECP HHHHHHHHHHHCCCC | 52.18 | - | |
| 592 | Ubiquitination | TRTYSLGKSSRGLKI EEEEECCCCCCCCEE | 51.02 | - | |
| 598 | Acetylation | GKSSRGLKIYAMEIS CCCCCCCEEEEEEEC | 36.17 | 20167786 | |
| 716 | Ubiquitination | LWGAEERKWVPYRVP CCCCCCCCCCCCCCC | 56.68 | - | |
| 884 | Phosphorylation | CDKFPHESELPREWE CCCCCCCCCCCCCHH | 41.20 | 20860994 | |
| 894 | Ubiquitination | PREWENNKEALLTFM CCCHHCCHHHHHHHH | 56.81 | 29967540 | |
| 922 | N-linked_Glycosylation | EQGIPIANATISVSG CCCCEECCEEEEEEC | 38.03 | 19159218 | |
| 1083 | O-linked_Glycosylation | AGWEESETETYTEVV CCCCCCCCEEEEEHH | 42.79 | OGP | |
| 1087 | O-linked_Glycosylation | ESETETYTEVVTEFG CCCCEEEEEHHHCCC | 29.71 | OGP | |
| 1091 | O-linked_Glycosylation | ETYTEVVTEFGTEVE EEEEEHHHCCCCEEC | 30.67 | OGP | |
| 1095 | O-linked_Glycosylation | EVVTEFGTEVEPEFG EHHHCCCCEECCCCC | 42.02 | OGP | |
| 1146 | O-linked_Glycosylation | TGQAFPFTTVETYTV HCCCCCCEEEEEEEE | 30.12 | OGP | |
| 1147 | O-linked_Glycosylation | GQAFPFTTVETYTVN CCCCCCEEEEEEEEE | 19.41 | OGP | |
| 1152 | O-linked_Glycosylation | FTTVETYTVNFGDF- CEEEEEEEEECCCC- | 19.18 | OGP |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AEBP1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AEBP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AEBP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of AEBP1_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-528 AND ASN-922, AND MASSSPECTROMETRY. | |